What Researchers Did
Researchers retrospectively analyzed 98 patients diagnosed with slow coronary flow, comparing those receiving conventional treatment only to those also receiving four weeks of hyperbaric oxygen therapy, evaluating effects using gated myocardial perfusion tomography.
What They Found
They found that 71.5% (108 out of 151) of injured myocardial subsegments improved in the hyperbaric oxygen group compared to 47.9% (71 out of 148) in the control group (P < 0.05). Furthermore, peak filling rate, time of peak filling rate, and mean filling rate during the first one-third of filling time significantly improved with hyperbaric oxygen, though left ventricular end diastolic volume, end systolic volume, and ejection fraction did not.
What This Means for Canadian Patients
Canadian patients with slow coronary flow might benefit from hyperbaric oxygen therapy as an adjunct to conventional treatment, potentially improving myocardial perfusion and left ventricular diastolic function. This could offer an additional therapeutic option to enhance heart health outcomes for those affected by this condition.
Canadian Relevance
This study has no direct Canadian connection mentioned in the metadata or abstract.
Study Limitations
A limitation of this study is its retrospective design and relatively small sample size, which may limit the generalizability of the findings.